A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
暂无分享,去创建一个
G. Honda | T. Takada | G. Wakabayashi | I. Endo | M. Miyazaki | Masakazu Yamamoto | E. Hatano | K. Hasegawa | H. Baba | S. Uemoto | H. Yamaue | M. Ueno | N. Kokudo | Y. Sakamoto | T. Kosuge | T. Beppu | H. Nitta | H. Takamura | T. Ohta | Kuniya Tanaka | Keiichi Takahashi | Y. Kotera | H. Yoshidome | Ken Kikuchi
[1] D. Gorden,et al. Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] H. Baba,et al. FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases. , 2010, Anticancer research.
[3] G. Choi,et al. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer. , 2009, Anticancer research.
[4] M. Choti,et al. Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 1669 Patients , 2009, Annals of surgery.
[5] M. Koch,et al. Validation of Prognostic Scoring Systems for Patients Undergoing Resection of Colorectal Cancer Liver Metastases , 2009, Annals of Surgical Oncology.
[6] H. Baba,et al. Thermal Ablation for Non-colorectal Liver M etastases , 2009 .
[7] Thomas Gruenberger,et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.
[8] M. Kattan,et al. A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal Cancer , 2008, Annals of surgery.
[9] Tomoyuki Kato,et al. Prognostic Models for Predicting Death after Hepatectomy in Individuals with Hepatic Metastases from Colorectal Cancer , 2008, World Journal of Surgery.
[10] P. Tekkis,et al. Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer: A Multifactorial Model of 929 Patients , 2008, Annals of surgery.
[11] H. Malik,et al. Preoperative Prognostic Score for Predicting Survival After Hepatic Resection for Colorectal Liver Metastases , 2007, Annals of surgery.
[12] J. Donohue,et al. Hepatic Resection for Colorectal Metastases: Value for Risk Scoring Systems? , 2007, Annals of surgery.
[13] C. Köhne,et al. Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial , 2007 .
[14] P. Catalano,et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Bosset,et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] F. Lévi,et al. Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.
[17] G. Maddern,et al. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. , 2004, Archives of surgery.
[18] Bernard Paule,et al. Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.
[19] F. Giuliante,et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] H. Bismuth,et al. Liver Resection for Colorectal Metastases: The Third Hepatectomy , 2003, Annals of surgery.
[22] M. Miyazaki,et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival , 2002, The British journal of surgery.
[23] K. Arisawa,et al. Difference in Prognostic Value Between Sialyl Lewisa and Sialyl Lewisx Antigen Levels in the Preoperative Serum of Gastric Cancer Patients , 2002, Journal of clinical gastroenterology.
[24] J. Figueras,et al. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases , 2001, The British journal of surgery.
[25] L H Blumgart,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.
[26] T. Starzl,et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. , 1999, Journal of the American College of Surgeons.
[27] B. Nordlinger,et al. Long‐term survival following resection of colorectal hepatic metastases , 1997, The British journal of surgery.
[28] F. Lévi,et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. , 1996, Annals of surgery.
[29] B. Nordlinger,et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.
[30] A. Altendorf-Hofmann,et al. Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.
[31] R. Parks,et al. Perioperative chemotherapy with FOLFOX 4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC Intergroup trial 40983 ) : a randomised controlled trial , 2008 .
[32] Masayuki Watanabe,et al. Thermal Ablation for Colorectal Liver Metastases , 2008 .
[33] B. Nordlinger,et al. Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. , 1997, The British journal of surgery.